Definitions for haemophilia prophylaxis and its outcomes: the Canadian consensus study.
about
Generic and disease-specific quality of life among youth and young men with Hemophilia in Canada.Optimizing outcomes for patients with severe haemophilia A.Choosing outcome assessment tools in haemophilia care and research: a multidisciplinary perspective.Home treatment of haemarthrosis with recombinant activated factor VII in patients with haemophilia A or B and inhibitors: experience from developing countries.Validation of a new pediatric joint scoring system from the International Hemophilia Prophylaxis Study Group: validity of the hemophilia joint health score.Adherence to prophylaxis and bleeding outcome in haemophilia: a multicentre study.Recombinant long-acting glycoPEGylated factor IX (nonacog beta pegol) in haemophilia B: assessment of target joints in multinational phase 3 clinical trials.Experience with central venous access devices (CVADs) in the Canadian hemophilia primary prophylaxis study (CHPS).Adherence to prophylaxis and quality of life in children and adolescents with severe haemophilia A.Joint Health Status of Hemophilia Patients in Jodhpur Region.Comparing the burden of illness of haemophilia between resource-constrained and unconstrained countries: the São Paulo-Toronto Hemophilia Study.Pilot study of once-a-day prophylaxis for youth and young adults with severe haemophilia A.Definitions in hemophilia: communication from the SSC of the ISTH.Age at first joint bleed and bleeding severity in boys with severe hemophilia A: Canadian Hemophilia Primary Prophylaxis Study.A new modeling approach allowing prediction and comparison of the long-term outcomes of treatments for hemophilia B.Joint health and functional ability in children with haemophilia who receive intensive replacement therapy.European principles of haemophilia care.Magnetic resonance imaging and joint outcomes in boys with severe hemophilia A treated with tailored primary prophylaxis in Canada.Haemophilia in a real-world setting: the value of clinical experience in data collection.A cohort study of the usefulness of primary prophylaxis in patients with severe haemophilia A.Updates in clinical trial data of extended half-life recombinant factor IX products for the treatment of haemophilia B
P2860
Q36011892-5185CB6D-D033-4F0E-9E92-2D3A53979BE1Q36932769-9D27BB6D-2EC5-41D4-B5A6-EB5E5B097DDFQ38955500-66398656-ABD5-4FC6-A2A6-28FE9E00816EQ39173721-81C50351-33DC-41BB-B6E4-1EAEDCA27CCBQ39834857-F57482B2-FA89-40A3-B3BE-3CD6BCD5828BQ39835946-9537CBF2-38BF-40A5-99A3-61C1B82AF082Q39952685-3713B629-D808-435D-8554-62A154584E52Q41143756-ADA15A96-F960-4E99-8AB4-780599ADB083Q41483187-00D5DA42-3795-47CE-B003-94581A00059DQ42483663-A92E463F-A3F2-42B4-9EB7-C8C38D671028Q44871911-3714304D-A27B-4287-8ED0-1688CE3CAA0CQ45857037-757226BF-F3AE-473D-8FF1-675641DEA2EAQ45867149-4AE6AC6F-3AE5-4D4B-98A2-D4201303A118Q45867203-5B5316E9-6C4B-4F02-B8E9-034CEFF1E601Q45868343-E882F09D-9EDF-47F8-85C0-E9CD5069A45EQ45872107-99ACEBC7-0CB6-45E3-99F6-1110B486980BQ45874963-C0B44CE8-A602-4E07-9E1F-BAC4363BD288Q45882524-0F288B6A-4687-4D38-A3E8-841B4487C9BEQ45882636-E078A5DF-740F-4F90-B75B-C4AAAF83651EQ45885496-89D9B0AB-8EF7-4CA7-842D-560B582563E1Q58583115-42607EDB-7483-49A9-A2C6-012C8A5A64CC
P2860
Definitions for haemophilia prophylaxis and its outcomes: the Canadian consensus study.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Definitions for haemophilia prophylaxis and its outcomes: the Canadian consensus study.
@ast
Definitions for haemophilia prophylaxis and its outcomes: the Canadian consensus study.
@en
type
label
Definitions for haemophilia prophylaxis and its outcomes: the Canadian consensus study.
@ast
Definitions for haemophilia prophylaxis and its outcomes: the Canadian consensus study.
@en
prefLabel
Definitions for haemophilia prophylaxis and its outcomes: the Canadian consensus study.
@ast
Definitions for haemophilia prophylaxis and its outcomes: the Canadian consensus study.
@en
P2093
P2860
P1433
P1476
Definitions for haemophilia prophylaxis and its outcomes: the Canadian consensus study.
@en
P2093
Blanchette VS
Feldman BM
Mclimont M
P2860
P356
10.1111/J.1365-2516.2006.01409.X
P577
2007-01-01T00:00:00Z